Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Wednesday 03 December 2014 10:28 am  |  Updated:  Friday 07 June 2019 5:45 pm

Parkinson’s app uMotif is the first app to be prescribed on the NHS

By: Emma Haslett

Add as a preferred source on Google

The NHS has just started prescribing its first app – from now on, patients with conditions such as diabetes, heart failure and Parkinsons can use uMotif, developed by a London-based startup, to monitor their health,

The app works by monitoring patients' blood pressure, blood glucose – and even includes a pedometer. Using the data it gets from them, it can issue patients with reminders, and help doctors to assess how well they are doing between appointments. To get access to it, patients are given a code on their prescription, and they can then download it from the iTunes or Android app store.

With the popularity of apps like MyFitnessPal, not to mention FitBug-style activity trackers, the logging of daily activity has become a pretty common thing. uMotif chief executive Bruce Hellman said we're at the "tipping point where digital health is about to start exploding and technology can really help to put people at the heart of their care".

At the moment, the app is being trialled for treatment of Parkinson's and diabetes, but it will be widened out across 17 NHS organisations. The idea is that it helps clinicians to develop on the NHS National Information Board's plans to "put patents at the centre of their care using technology" (although we'd hope patients were at the centre of their care already…).

The app can even link in with other healthcare applications, like Microsoft HealthVault. So following that £12bn IT bungle which crippled the NHS back in 2011, it looks like the service is finally getting its teeth into technology…

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • NHS

Trending Articles

  • Revealed: Secret Treasury plan to tax State Pension before it is paid out

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Burnham’s new chief of staff ran City firm advising Thames Water and rival Heathrow bidder

  • Barclays and Lloyds join banking sector plan for digital ID

  • Clarkson’s Farm and why businesses must stop blaming the weather

More from City PM

  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

    Business Wire
  • Harley Street Health District Releases First Annual Impact Report

    Business Wire
  • LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea

    Business Wire
  • Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy